Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study-Reference-Cited by-同舟云学术

Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study

Published:2007-06-06 Issue:11 Volume:99 Page:838-846
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Taguchi Fumiko,Solomon Benjamin,Gregorc Vanesa,Roder Heinrich,Gray Robert,Kasahara Kazuo,Nishio Makoto,Brahmer Julie,Spreafico Anna,Ludovini Vienna,Massion Pierre P.,Dziadziuszko Rafal,Schiller Joan,Grigorieva Julia,Tsypin Maxim,Hunsucker Stephen W.,Caprioli Richard,Duncan Mark W.,Hirsch Fred R.,Bunn Paul A.,Carbone David P.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/99/11/838/18614726/djk195.pdf

Reference30 articles.

1. ErbB-targeted therapeutic approaches in human cancer;Arteaga;Exp Cell Res,2003

2. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J Clin Oncol,2003

3. Erlotinib in lung cancer—molecular and clinical predictors of outcome;Tsao;N Engl J Med,2005

4. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

5. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer);Thatcher;Lancet,2005

Cited by 276 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on trends in development and translation of omics signatures in cancer;Computational and Structural Biotechnology Journal;2024-12

2. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14

3. Forensic Aspects of Mass Spectroscopy and Isotope Ratio Mass Spectroscopy;Advances in Analytical Techniques for Forensic Investigation;2024-08-05

4. Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy;Clinical Proteomics;2024-05-19

5. Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade;Journal of Experimental & Clinical Cancer Research;2024-03-16